The first intron of the human osteopontin gene contains a C/EBP-beta-responsive enhancer

Gene Expression

Volumn 11, Issue 2, 2003, Pages 95-104

  Giacopelli, Francesca ^a   Rosatto, Nadia ^a   Divizia, Maria Teresa ^a   Cusano, Roberto ^a   Caridi, Gianluca ^a   Ravazzolo, Roberto ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

C EBP beta; Enhancer; Osteopontin; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; OSTEOPONTIN; TRANSCRIPTION FACTOR;

ALLELE; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; ENHANCER REGION; EXON; FIBROSIS; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRON; NONHUMAN; ORGAN INJURY; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION INITIATION SITE;

ANIMALIA;

EID: 0038045063     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003108748991     Document Type: Article

References (21)

1. Akira, S.; Isshiki, H.; Sugita, T.; Tanabe, O.; Kinoshita, S.; Nishio, Y.; Nakajima, T.; Hirano, T.; Kishimoto, T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-1906; 1990.
2. Bobola, N.; Hirsch, E.; Albini, A.; Altruda, F.; Noonan, D.; Ravazzolo, R. A single cis-acting element in a short promoter segment of the gene encoding the interphotoreceptor retinoid-binding protein confers tissue-specific expression. J. Biol. Chem. 270:1289-1294; 1995.
3. Botquin, V.; Hess, H.; Fuhrmann, G.; Anastassiadis, C.; Gross, M. K.; Vriend, G.; Scholer, H. R. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12:2073-2090; 1998.
4. Denhardt, D. T.; Guo, X. Osteopontin: A protein with diverse function. FASEB J. 7:475-482; 1993.
5. Denhardt, D. T.; Noda, M.; O'Regan, A. W.; Pavlin, D.; Berman, J. S. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107: 1055-1061; 2001.
6. Dignam, J. D.; Lebovitz, R. M.; Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated nuclei. Nucleic Acids Res. 11:1475-1489; 1983.
7. Gutierrez, S.; Javed, A.; Tennant, D. K.; van Rees, M.; Montecino, M.; Stein, G. S.; Stein, J. L.; Lian, J. B. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277:1316-1323; 2002.
8. Higuchi, R.; Krummel, B.; Saiki, R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucleic Acids Res. 16:7351-7367; 1988.
9. Iwasaki, H.; Shinohara, Y.; Ezura, Y.; Ishida, R.; Kodaira, M.; Kajita, M.; Nakajima, T.; Shiba, T.; Emi, M. Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals. J. Hum. Genet. 46: 544-546; 2001.
10. Kon, S.; Maeda, M.; Segawa, T.; Hagiwara, Y.; Horikoshi, Y.; Chikuma, S.; Tanaka, K.; Rashid, M. M.; Inobe, M.; Chambers, A. F.; Uede, T. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J. Cell. Biochem. 77:487-498; 2000.
11. Liaw, L.; Birk, D. E.; Ballas, C. B.; Whitsitt, J. S.; Davidson, J. M.; Hogan, B. L. M. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101:1468-1478; 1998.
12. Nemir, M.; Bhattacharyya, D.; Li, X.; Singh, K.; Mukherjee, A. B.; Mukherjee, B. B. Targeted Inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency. J. Biol. Chem. 275:969-976; 2000.
13. Nishioka, K.; Ohshima, S.; Umeshita-Sasai, M.; Yamaguchi, N.; Mima, T.; Nomura, S.; Murata, N.; Shimizu, M.; Miyake, T.; Yoshizaki, K.; Suemura, M.; Kishimoto, T.; Saeki, Y. Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPbeta and C/EBPdelta, in rheumatoid synovium. Arthritis Rheum. 43:1591-1596; 2000.
14. Ohshima, S.; Kobayashi, H.; Yamaguchi, N.; Nishioka, K.; Umeshita-Sasai, M.; Mima, T.; Nomura, S.; Kon, S.; Inobe, M.; Uede, T.; Saeki, Y. Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: Possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum. 46:1094-2101; 2002.
15. Patrone, G.; Puliti, A.; Bocciardi, R.; Ravazzolo, R.; Romeo, G. Sequence and characterisation of the RET proto-oncogene 5′ flanking region: Analysis of retinoic acid responsiveness at the transcriptional level. FEBS Lett. 419:76-82; 1997.
16. Poli, V.; Mancini, F. P.; Cortese, R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63:643-653; 1990.
17. Rosati, M.; Valentin, A.; Patenaude, D. J.; Pavlakis, G. N. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: Increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J. Immunol. 167:1654-1662; 2001.
18. Trueblood, N. A.; Xie, Z.; Communal, C.; Sam, F.; Ngoy, S.; Liaw, L.; Jenkins, A. W.; Wang, J.; Sawyer, D. B.; Bing, O. H.; Apstein, C. S.; Colucci, W. S.; Singh, K. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ. Res. 88:1080-1087; 2001.
19. Wang, D.; Yamamoto, S.; Hijiya, N.; Benveniste, E.; Gladson, C. Transcriptional regulation of the human osteopontin promoter: Functional analysis and DNA-protein interactions. Oncogene 19:5801-5809; 2000.
20. Yamamoto, S.; Hijiya, N.; Setoguchi, M.; Matsuura, K.; Ishida, T.; Higuchi, Y.; Akizuki, S. Structure of the osteopontin gene and its promoter. Ann. NY Acad. Sci. 760:44-58; 1995.
21. Yoshitake, H.; Rittling, S. R.; Denhardt, D. T.; Noda, M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc. Natl. Acad. Sci. USA 96:8156-8160; 1999.